Big Bang Theory, page-10

Wales i believe the potential here for Xanamem is huge and that is the the feel i got from industry people in the pharma space while chatting to them. Don't forget ACW's Bill Ketelby took Pfizer's lead Alzheimer's drug Aricept to commercialisation and is here at ACW to do the same. I believe Pfizer for 1 but other larger pharma are very interested here due to Dr Ketelby's presence. He believes Xanamem is a potentially ground breaking drug in the space and many eyes are on him in the key pharma space knowing this. Xanamem has the potential as a different novel approach which can also be used in combination treatment with existing Alzheimer's drugs which would lead to bigger potential sales of the drug.

Any new drug hitting the Alzheimer's space is bound for US$ 10 billion in sales per year so Xanamem as a takeover target is primed and could see a massive take over offer as early as Aug/Sept i believe. The space has already seen takeovers and buyouts in the billions so the upside here is mind blowing for holders and anyone positioning themselves here at these levels. The 10c barrier has been a hard nut to crack but once it does this will run hard. This is still only a 60 mill market cap with a drug that has potential to be a prime takeover target in the billions like other recent takeovers in the space.